01 12Tarceva
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 10
2019 Revenue in Millions : 51
Growth (%) : -80
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 307
2018 Revenue in Millions : 554
Growth (%) : -45
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 178
2019 Revenue in Millions : 332
Growth (%) : -46
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 171
2017 Revenue in Millions : 270
Growth (%) : -37%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 331
2015 Revenue in Millions : 443
Growth (%) : -25
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 288
2016 Revenue in Millions : 353
Growth (%) : -18
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 51
2018 Revenue in Millions : 563
Growth (%) : -91
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -3.50%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Oncology
Currency : USD
2015 Revenue in Millions : 1,305
2014 Revenue in Millions : 1,193
Growth (%) : -9%
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 1,014
2015 Revenue in Millions : 1,169
Growth (%) : -13
